These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3087115)

  • 1. [Mechanism of action of calcium antagonists on vascular smooth muscle].
    Kölling K
    Zentralbl Veterinarmed A; 1986 Feb; 33(2):99-110. PubMed ID: 3087115
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of calcium antagonists on the portal vein].
    Oomiya A; Kokumi N; Hagiwara Y; Hara T; Hirashima T
    Nihon Heikatsukin Gakkai Zasshi; 1985 Aug; 21(4):266-8. PubMed ID: 4094226
    [No Abstract]   [Full Text] [Related]  

  • 3. AK-2-38, a nifedipine analogue with potent smooth muscle calcium antagonist action and partial agonist effects on isolated guinea pig left atrium.
    Matowe WC; Akula M; Knaus EE; Wolowyk MW
    Proc West Pharmacol Soc; 1989; 32():305-7. PubMed ID: 2780609
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium antagonists and vascular smooth muscle.
    Flaim SF
    Prog Clin Biol Res; 1986; 219():311-52. PubMed ID: 3786324
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
    Zakhari S
    Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of calcium antagonists on intracellular calcium deposits].
    Raddino R; Poli E; Pelà G; Ferrari A; Ghirarduzzi A; Ferrari R
    Cardiologia; 1987 Apr; 32(4):395-9. PubMed ID: 3113731
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
    Altura BM; Altura BT
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats.
    Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L
    Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonistic action of N-ethyl perhexiline maleate].
    Meng HP; Zhang BH
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):239-43. PubMed ID: 2954371
    [No Abstract]   [Full Text] [Related]  

  • 13. Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein.
    Liu H; Sperelakis N
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1063-8. PubMed ID: 9365814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH
    Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle].
    Xiao HJ; Liu JH
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular smooth muscle cell apoptosis induced by 7-ketocholesterol was mediated via Ca2+ and inhibited by the calcium channel blocker nifedipine.
    Sasaki H; Watanabe F; Murano T; Miyashita Y; Shirai K
    Metabolism; 2007 Mar; 56(3):357-62. PubMed ID: 17292724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists and excitation of the vascular muscle membrane.
    Hermsmeyer K; Kuthe C
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S933-6. PubMed ID: 6085380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM; Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of vasoselective action of mebudipine, a new calcium channel blocker.
    Mirkhani H; Dirin M; Youssef-Zayeh I
    Vascul Pharmacol; 2004 Aug; 42(1):23-9. PubMed ID: 15664884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.